TrialCancer communications (London, England)2023

Positron emission tomography-adapted therapy in low-risk diffuse large B-cell lymphoma: results of a randomized, phase III, non-inferiority trial.

Qing Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.